Morning Briefing
Summaries of health policy coverage from major news organizations
GAVI Alliance Reaches Agreement With Drugmakers On Reduced-Price Pneumococcal Vaccines
Several drugmakers have reached an agreement "to supply up to 200 million doses a year of cut-price pneumococcal vaccines to developing nations," according to GAVI Alliance, Reuters reports. A formal announcement of the deal is expected "in the next couple of weeks," GAVI's Deputy Chief Executive Officer Helen Evans told the news service Thursday.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
